Pure Global

Glucose - India CDSCO Medical Device Registration

Glucose is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000348_5c7f3af01a0d0717fbe8124d35f581d3_54980d68fa18fcf8336814f019cf3d1a. This device is marketed under the brand name QuantILab. The license holder is Instrumentation Laboratory India Pvt Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Glucose
UID: IMP/IVD/2019/000348_5c7f3af01a0d0717fbe8124d35f581d3_54980d68fa18fcf8336814f019cf3d1a

Brand Name

QuantILab

Device Class

Class B

Approving Authority

CDSCO

Product Information

:Glucose (QuantILab) is intended for the quantitative in vitro diagnostic determination of glucose in human serum, plasma, urine and cerebrospinal fluid (QuantILab) using the ILab Chemistry Systems

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing